(Q37524979)

20 August 2017

1 reference

title

The renin-angiotensin system: an old, newly discovered player in immunoregulation (English)

1 reference

20 August 2017

Abdallah S Geara

1

1 reference

20 August 2017

Jamil Azzi

series ordinal

2

1 reference

20 August 2017

Mollie Jurewicz

series ordinal

3

1 reference

20 August 2017

Reza Abdi

series ordinal

4

1 reference

20 August 2017

language of work or name

1 reference

1 July 2009

1 reference

20 August 2017

published in

Transplantation Reviews

1 reference

20 August 2017

volume

23

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

151-158

1 reference

History about the discovery of the renin-angiotensin system

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The intrarenal renin-angiotensin system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Intrarenal angiotensin II: interstitial and cellular levels and site of production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Vasoactive hormones and renal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Role of immunocompetent cells in nonimmune renal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Inflammation and angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin Converting Enzyme: Induction by Steroids in Rabbit Alveolar Macrophages in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Expression of renin-angiotensin system genes in immature and mature dendritic cells identified using human cDNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Control of dendritic cell differentiation by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Leukocytes synthesize angiotensinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Regulation of T-cell function by endogenously produced angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Cultured myofibroblasts generate angiotensin peptides de novo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

TGF-beta1 and angiotensin networking in cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renal injury from angiotensin II-mediated hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The renin angiotensin system blockade in kidney transplantation: pros and cons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The natural history of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Transforming growth factor beta in tissue fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

TGF-beta in kidney fibrosis: a target for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Prediction of chronic renal allograft dysfunction from evaluations of TGF?1 and the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renal allograft protection with angiotensin II type 1 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensinogen variants and human hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin Converting Enzyme Genotype and Chronic Allograft Nephropathy in Protocol Biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Gene polymorphisms of the renin???angiotensin???aldosterone system and the risk of ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Association of angiotensin II type 2 receptor gene variant with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Angiotensin-converting enzyme inhibitors after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.04.002

10.1016/J.TRRE.2009.04.002

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference